Prof. Koji Kono has been appointed as the new CEO of FACO
その後の非公式なミーティングにおいて、日本癌治療学会国際委員会委員長である河野浩二先生が西山正彦先生の後任のFACO CEOに就任することが、日中韓のリーダーたちによって決定され、2024年11月1日に正式に河野CEO就任が認められました。
西山正彦先生は、2012年のFACO設立メンバーで初代理事長、また2016年から今までCEOとして、FACOのHQの運営を担っていました。西山先生、本当にお疲れ様でした。
During the 24th FACO Business Meeting held during the 62nd Annual Meeting of the Japan Society of Clinical Oncology in Fukuoka from 24 to 26 October, the direction of FACO's activities for the next three years was confirmed by the three countries: Korea, China, and Japan.
In a subsequent informal meeting, it was decided by the leaders from KSMO, CSCO and JSCO that Prof. Koji Kono, Chair of the International Committee of the JSCO, would succeed Prof. Masahiko Nishiyama as the CEO of FACO. Prof. Kono's appointment as CEO was officially recognized on 1 November 2024.
Prof. Masahiko Nishiyama, a founding member of FACO in 2012 and its first Chairman, has served as CEO since 2016, overseeing the operations of FACO's headquarters. Prof. Nishiyama, thank you very much for your hard work.